Trading has resumed for Moolec Science (MLEC, Financial) SA. This development marks a key moment for investors keeping an eye on the company's market activities. Moolec Science is focused on providing biotech solutions and its performance is closely watched by market analysts and investors alike. The resumption of trading could potentially influence MLEC's market behavior, as stakeholders assess the company's future prospects.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Moolec Science SA (MLEC, Financial) is $30.00 with a high estimate of $30.00 and a low estimate of $30.00. The average target implies an upside of 255.45% from the current price of $8.44. More detailed estimate data can be found on the Moolec Science SA (MLEC) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Moolec Science SA's (MLEC, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
